Our Strengths Quality Management System

EP-Link's Quality Control System

We have established a Quality Control Department as a specialized division responsible for our quality control. The Quality Control Department maintains and operates the Standard Operating Procedures for clinical trial site support operations, as well as manuals and operational tools for each type of work. In addition, it is responsible for specialized education (education related to the commissioning and implementation of site support services) and work to improve and homogenize the quality of site support services throughout the company through mutual collaboration with each branch and relevant departments.

Quality Management System図
  1. 01The Role of the Quality Control Department

    • Preparation and management of Standard Operating Procedures for clinical trial site support services
    • Creation of procedure manuals (templates) for medical institutions
    • Review and implementation of measures to ensure quality throughout the company
    • Handling of inquiries about questions (concerning GCP ministerial ordinances, etc.) in support of clinical trial sites
    • QC inspections (visits to sites to evaluate the appropriateness of CRC work procedures and clinical trial data)
    • Planning, drafting, and operation of professional education and training programs
  2. 02Process Management in Clinical Trials

    We support and promote risk-based process management at medical institutions to ensure the quality of clinical trial data.
    Our CRCs, Site Management Associates (clinical trial secretariat staff) and business development staff for sites support the establishment of a clinical trial implementation system and processes, in consultation with the investigator and site staff. In addition, quality control staff and a quality promotion manager visit the site and inspect from a third party's perspective to ensure that clinical trial operations are being conducted in accordance with the process.

    Clinical Trial Process Management
    1. STEP 01

      Establishment of Clinical Trial Implementation System

      • Approach to medical institutions/
        investigators
    2. STEP 02

      Building Processes

      • Risk extraction
      • Establishment of processes according to risk
      • Process clarification through documentation
    3. STEP 03

      Conducting
      clinical Trials

      • Clinical trial operations in accordance with the process
    4. STEP 04

      Confirmation of
      clinical trial operations

      • Checks by quality control/quality promotion manager (site visit)
    5. STEP 05

      Process Review

      • Process optimization
      • Root cause analysis of deviations that occurred
      • Establishment of recurrence prevention measures

    Key Points for Quality Control/
    Quality Promotion Manager to Inspect Operations

    • Start of Clinical Trial

      • Establishment of processes according to risk
      • Identification of source documents
      • Sharing of the process among the parties involved in the clinical trial
    • During Clinical Trial

      • Compliance with processes
      • Process validity
      • Source document creation following ALCOA
      • Storage of source documents
    • Follow-up

      • Status of improvement of concerned issues
      • Status of implementation of measures to prevent recurrence of deviations/accidents
      • Status of source documents in storage toward the end of the study
  3. 03Risk Management

    The Quality Control Department centrally manages company-wide incident information through a reporting system. When an accident occurs, the department responds promptly and appropriately in cooperation with related parties and relevant departments. After an accident occurs, the Quality Control Department investigates and analyzes the incident/accident and the factors behind the case, and a specialized committee (Incident/Accident Subcommittee) investigates the cause of the case, examines measures to prevent recurrence, and promptly implements these measures in order to prevent recurrence.

    We are committed to compliance and ensuring the reliability of clinical trial data.

Related pages